Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning

Coronary Artery Disease

Volumn 7, Issue 4, 1996, Pages 305-314

  Haessler, Reinhard ^a   Kuzume, Koh ^c   Wolff, Roger A ^a   Kuzume, Kazuyo ^c   Chien, Grace L ^a,b   Davis, Richard F ^a,b   Van Winkle, Donna M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c EHIME UNIVERSITY   (Japan)

Author keywords

adenosine; adrenergic receptors; ischemia; myocardial infarction; rabbits

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; NORADRENALIN; PHENTOLAMINE; PRAZOSIN; TYRAMINE;

ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CORE TEMPERATURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEART VENTRICLE FIBRILLATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; RECEPTOR BLOCKING; REVIEW;

EID: 0029767969     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199604000-00007     Document Type: Review

References (35)

1. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
2. Schott RJ, Rohmann S, Braun ER, Schaper W: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990, 66:1133-1142.
3. Van Winkle DM, Thornton J, Downey DM, Downey JM: The natural history of preconditioning. Cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coronary Artery Dis 1991, 2:613-619.
4. Gross GJ, Auchampach JA: Blockade of ATP-sensrtive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992, 70:223-233.
5. Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB: Ischemic preconditioning limits Infarct size in the rat heart. Cardiovasc Res 1992, 26:983-987.
6. Lawson CS: Preconditioning in man: progress and prospects. J Mol Cell Cardiol 1995, 27:961-967.
7. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann H, Laskey WK: Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1991, 82:2044-2051.
8. Yellon DM, Alkhulaifi AM, Pugsley WB: Preconditioning the human myocardium. Lancet 1993, 342:276-277.
9. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM: Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 1995, 27:1349-1357.
10. Downey JM, Liu GS, Thornton JD: Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 1993, 27:3-8.
11. Toombs CF, Moore TL, Shebuski RJ: Limitation of infarct size in the rabbit by ischemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993, 27:617-622.
12. ATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res 1994, 28:1337-1341.
13. 1-adrenergic mechanism. Circ Res 1993, 73:656-670.
14. 1-Adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 1994, 95:2197-2205.
15. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, et al.: Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981, 101:593-600.
16. 1-adrenoceptor-mediated positive inotropic effect in rabbit papillary muscles. Br J Pharmacol 1993, 109:1232-1238.
17. Thornton JD, Daly JF, Cohen MV, Yang X-M, Downey JM: Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 1993, 73:649-655.
18. 1-Adrenoceptor stimulation with exogenous norepinephrine release or release of endogenous catecholamines mimics ischemic preconditioning Circulation 1994, 90:1023-1028.
19. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994, 75:576-585.
20. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T: Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation 1993, 87:208-215.
21. Van Wylen DGL: Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994, 89:2283-2289.
22. Olsson RA: Changes in content of purine nucleoside in canine myocardium during coronary occlusion. Circ Res 1970, 26:301-306.
23. 2-adrenergic receptors. FASEB J 1992, 6:832-839.
24. Summers RJ, McMartin LR: Adrenoceptors and their second messenger systems. J Neurochem 1993, 60:10-23.
25. Schulz R, Rose J, Heusch G: Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol 1994, 267:H1341-H1352.
26. ATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts. Eur J Pharmacol 1995, 277:271-274.
27. 1 adenosine receptors in rabbit heart. Circulation 1991, 84:350-356.
28. Miura T, Iimura O: Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine. Cardiovasc Res 1993, 27:36-42.
29. 1 receptor agonist R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits. Cardiovasc Res 1993, 27:2140-2145.
30. Reimer KA, Jennings RB: The 'wavefront phenomenon' of myocardial ischemic death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979, 40:633-644.
31. Maxwell MP, Hearse DJ, Yellon DM: Species variation in the coronary collateral circulation during regional myocardial ischemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987, 21:741-746.
32. Ytrehus K, Cohen MV, Downey J: Volume of risk zone influences infarct size in rabbits and may account for unexplained variability in infarction studies [abstract]. Circulation 1993, 88:1137.
33. Ytrehus K, Liu Y, Tsuchida A, Miura T, Liu GS, Yang X-M, et al.: Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 1994, 267:H2383-H2390.
34. Chien GL, Wolff RA, Davis RF, Van Winkle DM: 'Normothermic range' temperature affects myocardial infarct size. Cardiovasc Res 1994, 28:1014-1017.
35. Van Winkle DM, Matsuki T, Gad NM, Jordan MC, Downey JM: Left ventricular unloading during reperfusion does not limit myocardial infarct size. Circulation 1990, 81:1374-1379.